Models of Tau pathology related to frontotemporal dementia (FTD) are essential to determine underlying neurodegenerative pathologies and resulting tauopathy relevant behavioural changes. However, existing models are often limited in their translational value due to Tau overexpression, and the frequent occurrence of motor deficits which prevent comprehensive behavioural assessments. In order to address these limitations, a forebrainspecific (CaMKIIα promoter), human mutated Tau (hTau P301L + R406W ) knock-in mouse was generated out of the previously characterised PLB1 Triple mouse, and named PLB2 Tau . After confirmation of an additional hTau species (~60 kDa) in forebrain samples, we identified age-dependent progressive Tau phosphorylation which coincided with the emergence of FTD relevant behavioural traits. In line with the non-cognitive symptomatology of FTD, PLB2 Tau mice demonstrated early emerging (~6 months) phenotypes of heightened anxiety in the elevated plus maze, depressive/apathetic behaviour in a sucrose preference test and generally reduced exploratory activity in the absence of motor impairments. Investigations of cognitive performance indicated prominent dysfunctions in semantic memory, as assessed by social transmission of food preference, and in behavioural flexibility during spatial reversal learning in a home cage corner-learning task. Spatial learning was only mildly affected and task-specific, with impairments at 12 months of age in the corner learning but not in the water maze task. Electroencephalographic (EEG) investigations indicated a vigilance-stage specific loss of alpha power during wakefulness at both parietal and prefrontal recording sites, and site-specific EEG changes during non-rapid eye movement sleep (prefrontal) and rapid eye movement sleep (parietal). Further investigation of hippocampal electrophysiology conducted in slice preparations indicated a modest reduction in efficacy of synaptic transmission in the absence of altered synaptic plasticity. Together, our data demonstrate that the transgenic PLB2 Tau mouse model presents with a striking behavioural and physiological face validity relevant for FTD, driven by the low level expression of mutant FTD hTau.
Introduction
The excessive phosphorylation and reduced microtubule (MT) association of the Tau protein leads to the formation of insoluble inclusions that are prominent cellular pathologies in many types of frontotemporal dementia (FTD) (Goedert et al., 1988; Crowther, 1991) . Tau gene mutations underlie~5% of familial FTD cases with as many as 40% of all tauopathies, both sporadic and familial, presenting with Tau positive fronto-temporal lobar degeneration (see Neumann et al., 2009; Goedert et al., 2012 for reviews) . Functionally, the majority of exonic FTD Tau variants lead to the promotion of phosphorylation, decreased phosphatase association, diminished MT binding and an increased propensity for protein self-aggregation (Goedert and Spillantini, 2000) .
Despite a degree of shared common pathology between FTD tauopathies and Alzheimer's disease (AD), both dementias differ significantly in terms of early symptomatic presentation due to the divergent anatomical loci of neurodegeneration (Rabinovici et al., 2007) . FTD can be broadly subdivided into behavioural variant FTD (bvFTD), associated with degeneration of the prefrontal cortex, and semantic variant FTD (svFTD), in which temporal lobe degeneration is primary (Ghosh and Lippa, 2015) . Although executive dysfunction is common in both, svFTD is associated with varying language-based deficits, whilst bvFTD 
